IPOs in global biopharma industry surge to USD 8.52 billion in 2024: Report MD Bureau21 April 2025 12:30 PM ISTNew Delhi: The biopharmaceutical sector saw a notable resurgence in 2024, with initial public offerings (IPOs) soaring 68.4% globally to reach $8.52...
Biocon likely to list key biosimilars business by March 2026 Ruchika Sharma1 Feb 2025 2:30 PM ISTHyderabad: Biopharma major Biocon plans to introduce five new biosimilars in the United States in the new fiscal year, starting in April and is likely...
Shares of Emcure Pharma surges over 31 percent in debut trade Ruchika Sharma11 July 2024 12:30 PM ISTNew Delhi: Shares of Emcure Pharmaceuticals Ltd made a debut on Wednesday as they listed with a significant premium of over 31 percent against...
Nephro Care India IPO subscribed nearly 716 times Ruchika Sharma4 July 2024 2:30 PM ISTNew Delhi: Nephro Care India's initial public offering (IPO) was subscribed 715.85 times on Tuesday, largely driven by robust participation from...
Indian health insurer Niva Bupa files for Rs 3000 crore IPO Ruchika Sharma2 July 2024 11:30 AM ISTBengaluru: Niva Bupa, an Indian health insurer, has filed for an initial public offering (IPO) aiming to raise up to 30 billion rupees...
Emcure Pharma set to launch IPO on July 3 Ruchika Sharma30 Jun 2024 10:15 AM ISTEmcure Pharmaceuticals, backed by Bain Capital, is set to float its Initial Public Offering (IPO) on July 3. The initial share sale will run until...
Nephro Care India plans to raise Rs 35-40 crore via IPO Ruchika Sharma27 May 2024 12:45 PM ISTKolkata: Nephro Care India Ltd, a Kidney care provider said it plans to raise Rs 35-40 crore through an initial public offering (IPO)....
Akums Drugs and Pharma files draft IPO papers with Sebi Ruchika Sharma12 Feb 2024 11:30 AM ISTThe company is looking to raise Rs 136 crore through a pre-IPO placement.
Bayer Healthcare backed Metagenomi cuts US IPO valuation target to USD 563 million Ruchika Sharma11 Feb 2024 1:30 PM ISTNew Delhi: Genetic medicines company Metagenomi Technologies said on Thursday it is aiming for a valuation of $563 million in its U.S. initial...
Fractyl Health targets up to $762 mln valuation in US IPO Kajal Rajput30 Jan 2024 3:45 PM ISTBengaluru: Obesity and diabetes drug developer Fractyl Health said on Monday it was aiming for a market valuation of up to $762 million in its U.S....
Nephrocare India raises Rs 8.08 crore in pre-IPO round Ruchika Sharma1 Jan 2024 1:10 PM ISTThe fresh infusion of capital will fuel Nephrocare India's target of establishing 22 high-end kidney care facilities across India by March 2026.
Emcure Pharma aims to raise USD 400- USD 500 million from IPO planned for next year Ruchika Sharma26 Sept 2023 2:34 PM ISTIndia's pharmaceuticals market is expected to reach USD 130 billion in 2030 from USD 50 billion currently, and deal-making in the sector is booming.
